These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 6106210)

  • 1. [On the manufacture and testing of butaperazine matrix tablets with silicone varnish NH 30 as a structural substance (author's transl)].
    Kala H; Wendorff D; Moldenhauer H
    Pharmazie; 1980; 35(7):418-23. PubMed ID: 6106210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thermoplastic granulation as an alternative method for the preparation of hydrophilic-lipophilic oral matriix tablets].
    Dvorácková K; Rabisková M; Masteiková R; Vocilková L
    Ceska Slov Farm; 2007 Jun; 56(3):129-34. PubMed ID: 17867525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the solubility and the distribution behaviour of butaperazine dihydrogen maleate (author's transl)].
    Kala H; Wendorff D; Moldenhauer H
    Pharmazie; 1980; 34(5-6):306-10. PubMed ID: 6106207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of drug release kinetics of shellac-based matrix tablets by in-situ polymerization through annealing process.
    Limmatvapirat S; Limmatvapirat C; Puttipipatkhachorn S; Nunthanid J; Luangtana-anan M; Sriamornsak P
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1004-13. PubMed ID: 18362064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vivo testing of a 3-hydroxymethylpyridine hydrogen tartrate matrix tablet. Part 2: Comparison between the in vivo drug release from the matrix form and that from Radecol-tablets (author's transl)].
    Kala H; Danz R; Bekemeier H; Moldenhauer H
    Pharmazie; 1980; 35(4):216-21. PubMed ID: 7403243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-controlled pulse-drug release from dry-coated wax matrix tablets for colon drug delivery.
    Peerapattana J; Otsuka K; Otsuka M
    Biomed Mater Eng; 2004; 14(3):293-301. PubMed ID: 15299241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of ethanol on the in vitro and in vivo drug release from some sustained release tablets (author's transl)].
    Frömming KH; Topaloglu Y
    Arzneimittelforschung; 1975; 25(12):1958-64. PubMed ID: 3188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of various factors on in vitro output velocity from delayed-action tablets 1. Tetracycline delayed-action tablets].
    Tomassini L; Naplatanova D
    Pharmazie; 1973 Jul; 28(7):447-9. PubMed ID: 4767491
    [No Abstract]   [Full Text] [Related]  

  • 12. Sustained release phenylpropanolamine hydrochloride from ATO 888 matrix.
    Perez MA; Ghaly ES; Marti A
    P R Health Sci J; 1993 Dec; 12(4):263-7. PubMed ID: 8140204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation of sustained - release lithium carbonate matrix tablets: influence of hydrophilic materials on the release rate and in vitro-in vivo evaluation.
    Emami J; Tavakoli N; Movahedian A
    J Pharm Pharm Sci; 2004 Nov; 7(3):338-44. PubMed ID: 15576014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of an oral retard preparation of verapamil and absorption study in the anesthetized dog].
    Mayer D; Raschack M; Kesselring K
    Arzneimittelforschung; 1975 Aug; 25(8):1272-5. PubMed ID: 241362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
    Savaşer A; Ozkan Y; Işimer A
    Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Manufacture and in vitro characterization of a new fluid theophylline sustained-release form. Sachets with microcapsules for administration in a drinkable sustained-release suspension].
    Weiss G; Klemm FH; Fuchs WS; Stanislaus F; Zema M; Calanchi M
    Arzneimittelforschung; 1998 May; 48(5A):604-12. PubMed ID: 9676353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preparation and in vitro release of ginkgo biloba extract sustained-release tablets].
    Cui Q; Zhu Y; Cui J
    Zhongguo Zhong Yao Za Zhi; 2009 Aug; 34(15):1910-3. PubMed ID: 19894532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The factors influencing metoprolol succinate release from hydroxypropyl methylcellulose matrix tablet].
    Huang G; Wang R; Wang D; Zhang Z; Deng S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):587-91. PubMed ID: 16856395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Floating hot-melt extruded tablets for gastroretentive controlled drug release system.
    Fukuda M; Peppas NA; McGinity JW
    J Control Release; 2006 Oct; 115(2):121-9. PubMed ID: 16959356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.